10-Q · May 8, 2026
PRA Group delivered strong results in Q1 2026, significantly outperforming expectations with revenue of $314.5 million, surpassing estimates of $296.4 million, and diluted EPS of $0.73 compared to a consensus of $0.51.…
Earnings analysis · 10-Q
Filed August 7, 2026 · Our reading of the company's report
The latest report
PRA Group delivered strong Q2 results, with revenue up 29.4% year over year to $372.174 million, diluted EPS up 39.8% to $1.51, and cash collections up 4.2% to $558.545 million. Europe drove the earnings acceleration,…
PRA Group delivered strong Q2 results, with revenue up 29.4% year over year to $372.174 million, diluted EPS up 39.8% to $1.51, and cash collections up 4.2% to $558.545 million. Europe drove the earnings acceleration, while U.S. segment profit was broadly stable because higher legal collection costs offset revenue growth. Liquidity was adequate and operating cash burn improved materially, although portfolio purchases declined 14.4%, leverage remained high at $3.759 billion, and a large portion of revenue growth came from changes in expected recoveries.
How much of each revenue dollar the business keeps.
One point per quarterly or annual filing. Both margins are shares of that report's revenue.
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
Our analysis across the last few reports.
Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.
Q2 revenue was $372.174 million, up 29.4% from $287.688 million a year earlier and approximately 18.1% above Q1 2026 revenue of $315 million. Implied operating income was $153.282 million, or a 41.2% operating margin versus 29.6% in Q2 2025 and 32.8% in Q1 2026.
Diluted EPS was $1.51, up 39.8% from $1.08 in Q2 2025 and 107% from $0.73 in Q1 2026. Net income attributable to PRA Group increased to $57.917 million from $42.374 million year over year, a 36.7% increase.
Cash collections increased 4.2% year over year to $558.545 million, exceeding management's expectations. U.S. collections rose 5.8% to $291.112 million, driven by a $31.086 million, or 26.1%, increase in legal collections; Europe collections rose 3.7% to $218.078 million.
Europe was the primary earnings driver: external revenue increased $97.166 million, or 81.3%, and adjusted segment operating income increased $97.423 million, or 137.8%, to $168.146 million. Management attributed the revenue increase mainly to updated collection forecasts across most European pools.
Year-to-date operating cash use improved to $11.344 million from $65.490 million in the prior-year period, a $54.146 million improvement. Net cash increased $27.036 million year to date, despite $31.510 million of investing cash use.
Liquidity remained substantial, with $132.4 million of cash and cash equivalents and $998.468 million of total credit availability at June 30, 2026, including $733.096 million based on current ERC. Management also extended the European revolving facility maturity to April 30, 2031.
Portfolio purchases declined 14.4% year over year to $296.571 million in Q2 and 18.9% year to date to $517.421 million. U.S. purchases fell 40.0% to $109.447 million, highlighting supply, pricing or return-threshold constraints despite management's view that European supply has increased.
Total operating expenses rose 8.1% year over year to $218.892 million, with legal collection costs increasing 39.8% to $52.525 million. U.S. expenses also included $4.9 million of reorganization costs, including $2.0 million of severance and $3.0 million of real-estate impairment and other expenses.
Borrowings increased 4.0% year over year to $3.759 billion, while net interest expense rose 3.2% to $64.363 million in Q2. Estimated interest, unused fees and principal payments total $247.7 million over the next 12 months, creating meaningful funding sensitivity.
Revenue growth was heavily influenced by changes in expected recoveries, which increased 191.1% year over year to $96.924 million, while the more predictable portfolio-income component grew only 6.7% to $267.799 million. This increases sensitivity to future collection-forecast revisions and portfolio performance.
Other-markets portfolio revenue declined 83.8% year over year to $4.994 million, primarily due to larger decreases in collection forecasts on certain pools. Net foreign exchange transaction results also included a $0.710 million loss in Q2.
The filing states there were no material changes to the risk factors disclosed in the 2025 Form 10-K. Nevertheless, the company remains exposed to collection performance, portfolio supply, regulatory, cybersecurity, AI, liquidity and interest-rate risks; a 50-basis-point rate move would change estimated next-12-month interest expense by $7.8 million.
No explicit numeric revenue or EPS guidance was provided. Management said funds from operations, existing cash and available borrowings should be sufficient for operations, planned capital expenditures, forward-flow commitments, debt maturities and additional portfolio purchases for at least the next 12 months; forward-flow agreements imply approximately $218.7 million of purchases over the next 12 months.
PRA Group delivered strong results in Q1 2026, significantly outperforming expectations with revenue of $314.5 million, surpassing estimates of $296.4 million, and diluted EPS of $0.73 compared to a consensus of $0.51.…
PRA Group repositioned in 2025 with a Q4 2025 reorganization into two reportable segments (U.S. and Europe) and a strategy focused on disciplined capital allocation, technology/AI modernization and people. Revenue…
PRA Group reported Q2 total revenues of $287,688,000 (up $3,459,000 or ~1.2% vs. $284,229,000 a year ago) and diluted EPS of $1.08 (vs. $0.54 in Q2 2024). Operating income fell to $85,111,000 (operating margin 29.6% vs.…
PRA Group reported total revenue of $255,586,000 for the three months ended March 31, 2024, up from $155,470,000 in the prior-year quarter, driven by stronger portfolio recoveries and favorable changes in expected…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.